Hsp90 is expressed and represents a therapeutic target in human oesophageal cancer using the inhibitor 17-allylamino-17-demethoxygeldanamycin

por Wu, X, Wanders, A, Wardega, P, Tinge, B, Gedda, L, Bergstrom, S, Sooman, L, Gullbo, J, Bergqvist, M, Hesselius, P, Lennartsson, J, Ekman, S
Publicado 2009